1. bookAHEAD OF PRINT
Journal Details
License
Format
Journal
eISSN
2501-062X
First Published
30 Mar 2015
Publication timeframe
4 times per year
Languages
English
access type Open Access

Serum Uric Acid as a Predictor of cardio-and cerebro-vascular diseases in Maintenance Hemodialysis Patients

Published Online: 08 Jan 2022
Page range: -
Received: 31 Oct 2021
Journal Details
License
Format
Journal
eISSN
2501-062X
First Published
30 Mar 2015
Publication timeframe
4 times per year
Languages
English
Abstract

Background: Hyperuricemia is associated with an increased risk of cardio-and cerebrovascular disease (CVD) in general population. However, in the hemodialysis (HD) patients, low serum uric acid (SUA) increases the risk of mortality. Considering that CVD is the principal cause of death among maintenance HD patients, the present study aimed to determine the predictive value of SUA for CVD outcome in this population.

Methods: In this two-year follow-up prospective study, 205 outpatients under maintenance HD were enrolled from March 2017 to 2020. Patients’ demographic data, underlying diseases, and the results of serum tests, as well as two-year follow-up results of CVD events and mortality were recorded.

Results: A total of 130 (63%) patients were eligible for analysis; 62.9% were male; mean age of participants was 59±13years. At follow-up, coronary artery disease was observed in 43.2%, peripheral artery disease in 26.5%, and cerebrovascular disease in 20.5%; angiography was required in 52.3% and 4.5% died of CVD. SUA was ≤5.4 mg/dL in 52 patients, 5.5-6.1 mg/dL in 19, and ≥6.2 mg/dL in 59 patients with significant difference based on mean age, sex distribution, occurrence of cerebrovascular disease and cardiovascular mortality (P<0.05). Patients with cerebrovascular disease had a significantly lower SUA levels (P=0.006). Logistic regression showed the significant effect of SUA on the occurrence of cerebrovascular disease (P=0.008).

Conclusion: Low SUA can predict two-year incidence of cerebrovascular disease in HD patients. However, SUA levels did not show significant predictive effect on two-year coronary events, peripheral artery disease and cardiovascular mortality.

Keywords

1. JHA V, GARCIA-GARCIA G, ISEKI K, LI Z, NAICKER S, PLATTNER B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260-72.10.1016/S0140-6736(13)60687-X Search in Google Scholar

2. CLARKSON KA, ROBINSON K. Life on dialysis: a lived experience. Nephrol Nurs J. 2010;37(1):29-35. Search in Google Scholar

3. CHUASUWAN A, POORIPUSSARAKUL S, THAKKINSTIAN A, INGSATHIT A, PATTANAPRATEEP O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. life outcomes. 2020;18(1):1-11. Search in Google Scholar

4. MOUSAVI SSB, SOLEIMANI A, MOUSAVI MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl. 2014;25(3):697-702.10.4103/1319-2442.132242 Search in Google Scholar

5. BELADI-MOUSAVI SS, ALEMZADEH-ANSARI MJ, ALEMZADEH-ANSARI MH, BELADIMOUSAVI M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012;6(6):452-56. Search in Google Scholar

6. COZZOLINO M, MANGANO M, STUCCHI A, CICERI P, CONTE F, GALASSI A. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant. 2018;33(suppl_3): iii28-iii34.10.1093/ndt/gfy174 Search in Google Scholar

7. COUSER WG, REMUZZI G, MENDIS S, TONELLI M. The contribution of chronic kidney disease to the global burden of major no communicable diseases. Kidney Int. 2011;80(12):1258-70.10.1038/ki.2011.368 Search in Google Scholar

8. OSSAREH S, FARROKHI F, ZEBARJADI M. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors. Iran J Kidney Dis. 2016;10(6):369-80. Search in Google Scholar

9. SOLTANI Z, RASHEED K, KAPUSTA DR, REISIN E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr. Hypertens. Rep. 2013;15(3):175-81. Search in Google Scholar

10. LATIF W, KARABOYAS A, TONG L, WINCHESTER JF, ARRINGTON CJ, PISONI RL, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470-77.10.2215/CJN.00670111 Search in Google Scholar

11. KIM CS, JIN D-C, YUN YC, BAE EH, MA SK, KIM SW. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Kidney Res Clin Pract. 2017;36(4):368-76.10.23876/j.krcp.2017.36.4.368 Search in Google Scholar

12. PARK C, OBI Y, STREJA E, RHEE CM, CATABAY CJ, VAZIRI ND, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750-57.10.1093/ndt/gfw419 Search in Google Scholar

13. BEBERASHVILI I, ERLICH A, AZAR A, SINUANI I, FELDMAN L, GORELIK O, et al. Longitudinal study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016;11(6):1015-23.10.2215/CJN.10400915 Search in Google Scholar

14. LOVRE D, SHAH S, SIHOTA A, FONSECA VA. Managing diabetes and cardiovascular risk in chronic kidney disease patients. Endocrinol Metab Clin. 2018;47(1):237-57.10.1016/j.ecl.2017.10.006 Search in Google Scholar

15. MURRAY T, GOLDBERG M. Chronic interstitial nephritis: etiologic factors. Ann Intern Med. 1975;82(4):453-55.10.7326/0003-4819-82-4-453 Search in Google Scholar

16. BEBERASHVILI I, SINUANI I, AZAR A, SHAPIRO G, FELDMAN L, STAV K, et al. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Nutr J. 2015;31(1):138-47.10.1016/j.nut.2014.06.012 Search in Google Scholar

17. FIRTH D. Bias Reduction of Maximum Likelihood Estimates. Biometrika 1993; 80(1):27–38.10.1093/biomet/80.1.27 Search in Google Scholar

18. HEINZE G, PLONER M, DUNKLER D, SOUTHWORTH H, HEINZE MG. “Package ‘logistf” (2020). Search in Google Scholar

19. KUCIRKA LM, GRAMS ME, LESSLER J, HALL EC, JAMES N, MASSIE AB, et al. Association of race and age with survival among patients undergoing dialysis. JAMA. 2011;306(6):620-26.10.1001/jama.2011.1127 Search in Google Scholar

20. CHANDRASHEKAR A, RAMAKRISHNAN S, RANGARAJAN D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206-13.10.4103/0971-4065.132985 Search in Google Scholar

21. ECKARDT K-U, KIM J, KRONENBERG F, ALJAMA P, ANKER SD, CANAUD B, et al. Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol. 2010;21(10):1765-75.10.1681/ASN.2009101017 Search in Google Scholar

22. GOODKIN DA, FULLER DS, ROBINSON BM, COMBE C, FLUCK R, MENDELSSOHN D, et al. Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):358-65.10.1681/ASN.2010020173 Search in Google Scholar

23. KREDIET RT, BALAFA O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6(8):451-60.10.1038/nrneph.2010.68 Search in Google Scholar

24. CHANG TI, STREJA E, SOOHOO M, KIM TW, RHEE CM, KOVESDY CP, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591-602.10.2215/CJN.08730816 Search in Google Scholar

25. RAJU D, LALITHA D, KIRANMAYI P. A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis. J Clinic Res Bioeth. 2013;4(1):1-5.10.4172/2155-9627.1000143 Search in Google Scholar

26. MIKOLASEVIC I, ŽUTELIJA M, MAVRINAC V, ORLIC L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc dis. 2017; 10:35-45.10.2147/IJNRD.S101808 Search in Google Scholar

27. ZHANG B, GAO C, YANG N, ZHANG W, SONG X, YIN J, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol. 2010;10(1):1-6.10.1186/1471-2377-10-82 Search in Google Scholar

28. CHIQUETE E, RUIZ-SANDOVAL JL, MURILLO-BONILLA LM, ARAUZ A, OROZCOVALERA DR, OCHOA-GUZMÁN A, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35(2):168-74.10.1159/000346603 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo